Lukas Langenegger
Project Leader and Co-Founder of hemotune AG
Lukas Langenegger coordinates the hemotune project and is responsible for business development. Together with Carlos Mora he co-founded the ETH spinoff hemotune AG, where he acts as CEO. After completing an apprenticeship in banking and working for UBS AG in several positions, Lukas studied Chemical- and Bioengineering at ETH Zurich and Massachusetts Institute of Technology (MIT) and holds a bachelor’s and master’s degree with distinction from ETH Zurich. Combining an entrepreneurial mindset with his background in economics and engineering, Lukas is passionate about bringing cutting-edge technology from research to real world applications untapping its full potential to the benefit of as many people as possible. Together with the hemotune team, Lukas successfully participated in several startup competitions and was awarded with a grant of the Gebert Rüf Stiftung.
Contact:
lukas.langenegger@wysszurich.ch
Carlos Mora
Project Manager Preclinical and Co-Founder of hemotune AG
Carlos Mora coordinates the biological evaluation and preclinical testing of the hemotune medical device used for magnetic blood purification therapy. Together with Lukas Langenegger he co-founded the ETH spinoff hemotune AG, where he acts as COO. Carlos has more than five years of experience in nanotechnology and biomaterial engineering and holds a PhD degree in Chemical- and Bioengineering and an MSc in Microbiology and Immunology with distinction both from ETH Zurich. During his PhD studies he focused on the behavior and interaction of nanoparticles in biological systems. In 2014, he has co-founded and successfully helped to build up the Swiss science and technology think tank reatch in the role of vice president.
Contact:
carlos.mora@wysszurich.ch
Meet the entire team behind hemotune and visit www.hemotune.ch.